Atezolimumab-R (Atezovance)
Product detail for Atezolimumab-R, INN: atezolimumab-r. Therapeutic area: Oncology. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-029
INN
atezolimumab-r
Therapeutic Area
Oncology
Status
Approved
Owner
Nadia Petrova
Created
2022-06-05
Last Updated
2024-01-23
Markets
8
Presentations
| Form | Strength | Route |
|---|---|---|
| Powder for injection | 400 mg | Subcutaneous |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-005 | Immunovant alfa | immunovant alfa | 45534-14-3 | biologic | Active |
| SUB-043 | Benzyl alcohol | benzyl alcohol | 29540-71-8 | combination | Active |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| SwissMedic-2021-0029 | Portugal | NDS | Active | Nadia Petrova | 2023-06-16 |
| Roszdravnadzor-2021-0059 | Portugal | BLA | Submitted | James O'Brien | 2023-03-01 |
| SwissMedic-2021-0089 | Portugal | Type II Variation | Completed | Tomoko Ikeda | 2022-09-24 |
Markets (8)